Sherif A El-Kafrawy

InstitutionKing Abdulaziz University
AddressJeddah
Saudi Arabia
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 15 Covid-19 publications, with a maximum of 3 publications in May 2021
    All Publications
    Bar chart showing 26 publications over 9 distinct years, with a maximum of 11 publications in 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Alshukairi AN, El-Kafrawy SA, Dada A, Yasir M, Yamani AH, Saeedi MF, Aljohaney A, AlJohani NI, Bahaudden HA, Alam I, Gojobori T, Radovanovic A, Alandijany TA, Othman NA, Alsubhi TL, Hassan AM, Tolah AM, Al-Tawfiq JA, Zumla A, Azhar EI. Re-infection with a different SARS-CoV-2 clade and prolonged viral shedding in a hematopoietic stem cell transplantation patient. Int J Infect Dis. 2021 Sep; 110:267-271. PMID: 34289407.
      Citations: 2     Fields:    Translation:Humans
    2. Farsi SH, Alandijany TA, Radwi M, Farsi A, Bahaaziq W, Abushoshah I, El-Kafrawy SA, Alsayed S, Azhar EI, Boker A. Prevalence of COVID-19 antibodies among operating room and critical care staff at a tertiary teaching hospital: A cross-sectional study. Saudi Med J. 2021 Jul; 42(7):742-749. PMID: 34187918.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    3. Tolah AMK, Sohrab SS, Tolah KMK, Hassan AM, El-Kafrawy SA, Azhar EI. Evaluation of a Pseudovirus Neutralization Assay for SARS-CoV-2 and Correlation with Live Virus-Based Micro Neutralization Assay. Diagnostics (Basel). 2021 May 30; 11(6). PMID: 34070824.
      Citations: 2     
    4. Alshukairi AN, Tolah AM, Dada A, Al-Tawfiq JA, Almagharbi RS, Saeedi MF, Al-Hamzi MA, El-Kafrawy SA, Bahaudden HA, El-Saed A, Al-Mozaini MA, Khalid I, Hefni LK, Hassan AM, Alandijany TA, Bajrai LH, Bayumi DT, Albishi GE, Althawadi SI, Zabani NA, Perlman S, Azhar EI. Test-based de-isolation in COVID-19 immunocompromised patients: Cycle threshold value versus SARS-CoV-2 viral culture. Int J Infect Dis. 2021 Jul; 108:112-115. PMID: 34004329.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    5. Faizo AA, Alandijany TA, Abbas AT, Sohrab SS, El-Kafrawy SA, Tolah AM, Hassan AM, Azhar EI. A Reliable Indirect ELISA Protocol for Detection of Human Antibodies Directed to SARS-CoV-2 NP Protein. Diagnostics (Basel). 2021 May 02; 11(5). PMID: 34063315.
      Citations: 2     
    6. El-Kafrawy SA, Sohrab SS, Mirza Z, Hassan AM, Alsaqaf F, Azhar EI. In Vitro Inhibitory Analysis of Rationally Designed siRNAs against MERS-CoV Replication in Huh7 Cells. Molecules. 2021 Apr 29; 26(9). PMID: 33947034.
      Citations:    Fields:    Translation:HumansCells
    7. Alsayed SM, Alandijany TA, El-Kafrawy SA, Hassan AM, Bajrai LH, Faizo AA, Mulla EA, Aljahdali LS, Alquthami KM, Zumla A, Azhar EI. Pattern of Respiratory Viruses among Pilgrims during 2019 Hajj Season Who Sought Healthcare Due to Severe Respiratory Symptoms. Pathogens. 2021 Mar 08; 10(3). PMID: 33800223.
      Citations:    
    8. Bharadwaj S, El-Kafrawy SA, Alandijany TA, Bajrai LH, Shah AA, Dubey A, Sahoo AK, Yadava U, Kamal MA, Azhar EI, Kang SG, Dwivedi VD. Structure-Based Identification of Natural Products as SARS-CoV-2 Mpro Antagonist from Echinacea angustifolia Using Computational Approaches. Viruses. 2021 02 15; 13(2). PMID: 33672054.
      Citations: 3     Fields:    Translation:AnimalsCells
    9. Ahmed WA, Dada A, Alshukairi AN, Sohrab SS, Faizo AA, Tolah AM, El-Kafrawy SA, Bajrai LH, Moalim HM, Aly MH, Aboelazm AF, Al-Hamzi MA, Saeedi MF, Alandijany TA, Azhar EI. Seroprevalence of neutralizing antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among healthcare workers in Makkah, Saudi Arabia. J King Saud Univ Sci. 2021 May; 33(3):101366. PMID: 33613011.
      Citations: 4     
    10. Alandijany TA, El-Kafrawy SA, Al-Ghamdi AA, Qashqari FS, Faizo AA, Tolah AM, Hassan AM, Sohrab SS, Hindawi SI, Badawi MA, Azhar EI. Lack of Antibodies to SARS-CoV-2 among Blood Donors during COVID-19 Lockdown: A Study from Saudi Arabia. Healthcare (Basel). 2021 Jan 05; 9(1). PMID: 33466554.
      Citations: 5     
    11. El-Kafrawy SA, El-Daly MM, Hassan AM, Kaki RM, Abuzenadah AM, Kamal MA, Azhar EI. A Direct Method for RT-PCR Detection of SARS-CoV-2 in Clinical Samples. Healthcare (Basel). 2021 Jan 04; 9(1). PMID: 33406585.
      Citations: 2     
    12. Azhar EI, Hindawi SI, El-Kafrawy SA, Hassan AM, Tolah AM, Alandijany TA, Bajrai LH, Damanhouri GA. Amotosalen and ultraviolet A light treatment efficiently inactivates severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human plasma. Vox Sang. 2021 Jul; 116(6):673-681. PMID: 33277935.
      Citations: 4     Fields:    Translation:Humans
    13. Alandijany TA, El-Kafrawy SA, Tolah AM, Sohrab SS, Faizo AA, Hassan AM, Alsubhi TL, Othman NA, Azhar EI. Development and Optimization of In-house ELISA for Detection of Human IgG Antibody to SARS-CoV-2 Full Length Spike Protein. Pathogens. 2020 Sep 28; 9(10). PMID: 32998438.
      Citations: 8     
    14. de Sousa E, Ligeiro D, Lérias JR, Zhang C, Agrati C, Osman M, El-Kafrawy SA, Azhar EI, Ippolito G, Wang FS, Zumla A, Maeurer M. Mortality in COVID-19 disease patients: Correlating the association of major histocompatibility complex (MHC) with severe acute respiratory syndrome 2 (SARS-CoV-2) variants. Int J Infect Dis. 2020 Sep; 98:454-459. PMID: 32693089.
      Citations: 15     Fields:    Translation:HumansCellsPHPublic Health
    15. Zumla A, Wang FS, Ippolito G, Petrosillo N, Agrati C, Azhar EI, Chang C, El-Kafrawy SA, Osman M, Zitvogel L, Galle PR, Locatelli F, Gorman E, Cordon-Cardo C, O'Kane C, McAuley D, Maeurer M. Reducing mortality and morbidity in patients with severe COVID-19 disease by advancing ongoing trials of Mesenchymal Stromal (stem) Cell (MSC) therapy - Achieving global consensus and visibility for cellular host-directed therapies. Int J Infect Dis. 2020 Jul; 96:431-439. PMID: 32425638.
      Citations: 20     Fields:    Translation:HumansCellsPHPublic Health
    El-Kafrawy's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (117)
    Explore
    _
    Co-Authors (112)
    Explore
    _
    Similar People (60)
    Explore
    _